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Abstract Lipopolysaccharide (LPS) is a potent inflammatory
agent which augments neutrophil sensitivity to subsequent
inflammatory stimuli. In this study, the effects of structurally
different LPS types upon neutrophil effector functions were
examined. Rough LPS types, which have lost the O-polysaccha-
ride moiety, were found to act more rapidly than smooth LPS
types in stimulating neutrophil L2 integrin activity and fMLP-
induced respiratory burst. These findings suggest an involvement
of the O-polysaccharide region of LPS in regulating neutrophil
responsiveness to different LPS chemotypes with important
implications for the mechanisms underlying regulation of the
inflammatory response in conditions associated with elevation of
LPS in plasma, e.g. septic shock or acute respiratory distress
syndrome.
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1. Introduction
Lipopolysaccharide (LPS), a component of the outer mem-
brane of Gram-negative bacteria, is a potent in£ammatory
mediator which involves production of pro-in£ammatory cy-
tokines and induces functional alterations in many cell types.
These e¡ects contribute to the generation of clinical symptoms
associated with septic shock [1] which may lead to develop-
ment of disease states such as acute respiratory distress syn-
drome [2,3]. LPS can increase neutrophil sensitivity to subse-
quent in£ammatory stimuli by ‘priming’ them for augmented
production of oxygen metabolites and secretion of granule
contents [4,5]. In addition, LPS can augment neutrophil ad-
hesiveness [6] which could result in an accumulation of neu-
trophils in the vasculature of the lung and other organs.
Although these functional alterations induced by LPS are
principally directed towards increased e⁄ciency of bacterial
clearance, under certain conditions, neutrophil-mediated tis-
sue damage may occur, thus contributing to disease patho-
genesis.
The e⁄ciency of LPS-mediated e¡ects is in£uenced by se-
rum components, including the well-characterised LPS bind-
ing protein (LBP) [7]. Several pathways for LPS-induced neu-
trophil activation have been proposed [8,9]. One pathway in-
volves the formation of a membrane (m) CD14 (a glycosyl
phosphatidyl inositol (GPI)-linked receptor for LPS)-CR3
complex [10]. Alternatively, interaction of LPS with either
mCD14 [11] or another distinct receptor [12] has been sug-
gested to mobilise putative signal-transducing molecules. Re-
cent evidence suggests that the L2 integrin CR3 could function
directly as an LPS signalling receptor [13]. Another pathway
has been suggested to involve soluble (s) CD14-LPS com-
plexes binding a novel receptor at the surface of cells which
lack mCD14 (e.g. non-myeloid cell types or cells from parox-
ysmal nocturnal haemoglobinuria patients which lack GPI-
linked receptors).
Most types of LPS are composed of three distinct regions:
the hydrophilic O-polysaccharide moiety of heterogeneous
length, the core oligosaccharide and the hydrophobic domain
known as lipid A. The lipid A moiety of LPS contains the
region of the LPS molecule which confers its ability to a¡ect
neutrophil function and this structure is highly conserved
among diverse species of Gram-negative bacteria [14]. Neutro-
phils are apparently especially discriminating with respect to
the chemical structure of lipid A. Deacylated LPS is not active
in priming neutrophils [15] and monophosphoryl lipid A does
not prime neutrophils, but does prime monocytes [16]. Thus,
chemical modi¢cation of lipid A by bacteria may confer
protection against host defence mechanisms. In keeping with
this suggestion, most enterobacteria, like Escherichia coli, pro-
duce LPS which has a hydrophilic O-polysaccharide moiety, a
core oligosaccharide and the hydrophobic lipid A domain
and is termed ‘smooth’ or ‘S-form’ chemotype. Loss of the
O-polysaccharide region results in LPS mutants of entero-
bacteria described as ‘rough’ or the ‘R-form’ chemotype of
LPS.
In this present study, we sought to investigate the mecha-
nisms of LPS action in priming neutrophil function by exam-
ining the e¡ect of smooth and rough chemotypes of LPS upon
neutrophil function. Here we report our detailed analysis
demonstrating that rough LPS (rLPS) acts more rapidly
than smooth LPS (sLPS) to cause functional alterations in
neutrophils. Activation of L2 integrin-mediated adhesion oc-
curred within 15 min following rLPS treatment whereas sLPS
was without e¡ect at this early time point. Rough LPS also
primed neutrophil formyl-Met-Leu-Phe (fMLP)-induced res-
piratory burst activity more rapidly. These ¢ndings suggest
that the O-polysaccharide moiety of LPS can profoundly in-
£uence the responsiveness of neutrophils to LPS with impor-
tant consequences for initiation and progression of the in£am-
matory response.
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2. Materials and methods
2.1. Antibodies and other reagents
Dextran T500 was obtained from Pharmacia Biotech Ltd (Milton
Keynes, UK). Hanks’ balanced salt solution (HBSS) was obtained
from Life Technologies (Paisley, UK). Human serum albumin,
fMLP peptide, cytochrome c and superoxide dismutase were obtained
from Sigma Chemical Co. (Poole, UK). Dihydrorhodamine (DHR
123) was purchased from Molecular Probes, Eugene, OR, USA (sup-
plied by Cambridge Bioscience, Cambridge, UK). Fluorescent latex
beads (1 Wm diameter) were from Polysciences Inc., Warrington, PA,
USA (supplied by Park Scienti¢c, Northampton, UK). FITC-conju-
gated F(abP)2 goat anti-mouse immunoglobulins were from DAKO.
Mouse mAb ICRF44 (CD11b) (IgG1) was obtained from Dr Nancy
Hogg and Leu-8 (CD62L) (IgG2b) was obtained from Becton Dick-
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Fig. 1. E¡ect of various LPS chemotypes upon neutrophil L2 integrin-dependent binding. A: Freshly isolated neutrophils (107/ml) were incu-
bated at 37‡C with 500 ng/ml LPS for 15 or 30 min in the presence of ACLB and binding assessed by £ow cytometry. Data represent the
mean percentage of neutrophils binding one or more ACLB þ S.E.M. of three di¡erent experiments. B: Histograms of a representative experi-
ment showing £ow cytometric determination of neutrophil binding to £uorescent ACLB in presence of rough (E. coli R1) or smooth LPS (E.
coli O18). Gate A represents one or more £uorescent beads bound to neutrophils.
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inson, High Wycombe, UK. All antibodies were used at a concentra-
tion that saturated binding as assessed by £ow cytometric analysis.
2.2. Neutrophil isolation
Polymorphonuclear leukocytes were isolated from peripheral blood
of healthy donors by dextran sedimentation and fractionation through
isotonic discontinuous Percoll gradients as previously described [17].
Polymorphonuclear leukocytes were found to be 95^98% neutrophils
by morphological criteria and viability was always s 99% as assessed
by trypan blue exclusion. Autologous platelet-depleted plasma was
prepared by centrifugation of platelet-rich plasma at 13 000Ug for
5 min.
2.3. Bacterial lipopolysaccharides
The di¡erent LPS types used in this study were extracted from
lyophilised bacteria by either the aqueous phenol method for smooth
chemotypes or petroleum/chloroform/phenol for rough chemotypes
[18]. Smooth LPS were from Escherichia coli O18, Bacterioides fragilis
NCTC9343 and Burkholderia cepacia and rough LPS from E. coli R1
and R3 and Salmonella minnesota R60 or Re595 and Salmonella ty-
phimurium Rc878. Stock solutions (1 mg/ml) in water were sonicated
and then stored at 320‡C. LPS from E. coli O111 was obtained from
Sigma (Poole, UK). Puri¢ed LPS types were sonicated for 2 min to
ensure uniform resuspension prior to ¢nal dilution in HBSS for the
experiments.
2.4. Measurement of neutrophil shape change and adhesion to
albumin-coated latex beads
The e¡ects of di¡erent LPS types upon neutrophil shape change
was determined by £ow cytometric analysis as previously described
[19] and veri¢ed by conventional light microscopic analysis of sam-
ples.
CD11b/CD18-dependent binding of albumin-coated latex beads
(ACLB) to neutrophils in the presence or absence of LPS was meas-
ured as previously described [19]. Both assays were performed in the
presence of 1% autologous platelet-depleted plasma.
2.5. Indirect immuno£uorescence £ow cytometry
Neutrophils (105 cells per test) were incubated with 50 Wl of satu-
rating concentrations of mAb for 30 min at 4‡C, then washed three
times with HBSS containing 0.2% bovine serum albumin (BSA) and
0.1% sodium azide to remove unbound mAb and incubated with 50 Wl
of FITC-conjugated F(abP)2 goat anti-mouse Ig (1:40) for 30 min at
4‡C. Neutrophils were then washed three times with HBSS/BSA/azide
prior to analysis by £ow cytometry using a Coulter Epics Pro¢le II
cytometer (Coulter Electronics, Luton, UK).
2.6. Measurement of endogenous oxidant production and superoxide
anion release
Production of reactive oxygen intermediates by neutrophils with
and without exposure to LPS was assessed by £ow cytometric deter-
mination of DHR 123 oxidation as previously described [19] in the
presence of 1% autologous platelet-poor plasma.
For determination of fMLP-induced release of superoxide anions,
neutrophils were pre-incubated with LPS in presence of 1% autolo-
gous plasma for 15 or 30 min followed by addition of HBSS or fMLP
(1037 M) and cytochrome c (1 mg/ml). Each assay was performed in
triplicate and also in the presence of superoxide dismutase (200 U/ml)
to con¢rm the speci¢city of cytochrome c reduction. After 15 min at
37‡C, the reaction was terminated by placing the cells on ice, followed
by centrifugation (13 000Ug, 3 min, 4‡C). The superoxide dismutase
inhibitable reduction of cytochrome c was determined for each super-
natant by measuring the peak absorbance between 535 and 565 nm
using a Pye-Unicam scanning spectrophotometer. Results are ex-
pressed as nanomoles of superoxide anions generated per 106 neutro-
phils calculated using the extinction coe⁄cient of 21U103 M31 cm31.
2.7. Statistical analysis
The mean with S.E.M. or S.D. was calculated from the means from
di¡erent experiments (di¡erent donors), each performed in triplicate.
Using Student’s t-test (paired, one-tailed), the signi¢cance of the dif-
ference between the mean of the assays and control groups was de-
termined. P values 6 0.05 were considered signi¢cant.
3. Results
3.1. Di¡erential e¡ects of LPS chemotypes upon neutrophil L2
integrin activity
Altered expression and function of L2 integrins occurs rap-
idly following receptor-mediated activation. Our previous
studies have shown that ACLB binding represents a sensitive
index of CD11b/CD18 functional activity [19]. We therefore
investigated the ability of di¡erent LPS chemotypes to induce
neutrophil L2 integrin activity. The e¡ect of LPS from seven
di¡erent species of bacteria, three smooth forms (sLPS) and
four rough forms (rLPS), on neutrophil binding to ACLB was
determined. In preliminary experiments, we found that there
was an absolute requirement for the presence of low concen-
trations of plasma for LPS-induced functional alterations in
neutrophils (data not shown). Surprisingly, signi¢cant di¡er-
ences were observed in temporal analyses of the e¡ects of LPS
chemotypes. Although the majority of neutrophils treated
with all LPS chemotypes for 30 min showed induction of
CD11b/CD18 functional activity as determined by ACLB
binding (Fig. 1A,B), a clear discrimination between the e¡ects
of smooth and rough LPS was seen after shorter pre-incuba-
tion times (Fig. 1 and data not shown). The observed di¡er-
ential e¡ects of LPS chemotypes upon neutrophil L2 integrin
function at 15 min were also paralleled by di¡erences in the
e¡ects of rLPS and sLPS upon neutrophil polarisation as
assessed by microscopic analysis and also the increase in for-
ward angle laser scatter of neutrophils in £ow cytometric
analysis (data not shown).
We next performed a detailed examination of the time
course of the e¡ects of the di¡erent LPS chemotypes in in-
ducing L2 integrin-dependent neutrophil binding to ACLB.
Data shown in Fig. 2 indicate that exposure of neutrophils
to rLPS rapidly induces L2 integrin activation (within 5 min),
whereas sLPS e¡ects were temporally delayed (within 20 min).
These data indicated that rough LPS acted more rapidly to
stimulate neutrophil function than smooth LPS.
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Fig. 2. Kinetics of e¡ects of rough and smooth LPS on L2 integrin
activity. Neutrophils were incubated at 37‡C with ACLB and 500
ng/ml LPS (E. coli O111 or R3) was added at di¡erent time points
indicated. Data represent the mean þ S.E.M. of 3^6 experiments.
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3.2. The di¡erential e¡ect of rLPS and sLPS is not due to a
di¡erence in molecular weight
The experiments described above compared equivalent
weight/volume concentrations of LPS. The average molecular
weight of sLPS is approximately four times more than that of
rLPS, thus rLPS contains at least four times more of the
active lipid A moiety than the equivalent weight of sLPS.
We therefore sought to determine whether the di¡erential ef-
fect of sLPS and rLPS was due to di¡erences in molecular
weight between rLPS and sLPS chemotypes.
We compared the concentration responses of rLPS and
sLPS for induction of L2 integrin-dependent ACLB binding
and also for alterations in expression of CD11b and CD62L.
At 15 min, rLPS augmented L2 integrin functional activity
at concentrations greater than 100 ng/ml (Fig. 3A). Expres-
sion of CD62L was reduced in a concentration dependent
manner in response to rLPS (Fig. 3C), consistent with the
suggestion that shedding of this receptor is a sensitive indica-
tor of neutrophil activation [20]. In contrast, a small and
variable e¡ect of sLPS upon CD62L expression was observed
at 15 min which failed to reach statistical signi¢cance
(Fig. 3C). Although expression of CD11b was increased
at higher concentrations of rLPS (500 ng/ml) at 15 min,
this failed to reach statistical signi¢cance representing an in-
crease of less than 25% relative to untreated cells (Fig. 3B).
Interestingly, induction of L2 integrin activity by rLPS oc-
curred at concentrations which did not augment CD11b ex-
pression, suggesting that rLPS e¡ects re£ected changes in re-
ceptors already present on the neutrophil surface and not
mobilisation of CD11b/CD18 from intracellular compart-
ments. In marked contrast to the e¡ects of rLPS, sLPS did
not alter L2 integrin functional activity or CD11b expression
(Fig. 3A,B). Whilst analysis of the e¡ects of various concen-
trations of rough and smooth LPS types upon neutrophil L2
integrin activation at 15 min revealed clear di¡erences, the
e¡ects of rough and smooth LPS types were indistinguishable
at 30 min. These data strongly suggest that the di¡erential
e¡ects of rough and smooth LPS upon neutrophil L2 integrin
activation cannot be simply explained by di¡erences in molec-
ular weight.
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Fig. 3. The di¡erential e¡ect of rough and smooth LPS is not due to a di¡erence in molecular weight. A: Neutrophils were incubated for 15
or 30 min at 37‡C with di¡erent concentrations of rough (E. coli R3) or smooth LPS (E. coli O111) in the presence of ACLB. B: Neutrophil
CD11b expression following incubation with rough or smooth LPS was assessed by £ow cytometry using an anti-CD11b mAb (44 mAb). C:
Neutrophil CD62L expression following incubation with rough or smooth LPS was assessed by £ow cytometry using an anti-CD62L mAb
(Leu-8 mAb). Data shown are the mean þ S.E.M. of three experiments.
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3.3. Smooth LPS does not compete with rLPS in neutrophil
binding to ACLB
We next considered the possibility that di¡erential glycosyl-
ation of smooth LPS might fail to initiate signalling pathways
despite e¡ective binding to the neutrophil surface. To test this
suggestion, we used a low concentration of rLPS (100 ng/ml)
which stimulated L2 integrin function, in the presence of in-
creasing concentrations of sLPS. Consistent with data shown
in Fig. 1, high concentrations (500 and 1000 ng/ml) of sLPS
did not a¡ect L2 integrin activity at 10 min, but caused max-
imal activation at 30 min (Fig. 4: compare HBSS+sLPS for
both time points). Thus, the sLPS used in these experiments
was capable of causing functional alterations in neutrophils.
However, despite the observation that sLPS was able to bind
and initiate signals which augment L2 integrin activity at 30
min, the presence of high concentrations of sLPS did not
interfere with the ability of low concentrations of rLPS to
rapidly augment L2 integrin ligand binding (Fig. 4). These
data raise the possibility that either sLPS binds more slowly
to the neutrophil surface than rLPS, or that the receptors
which mediate responses to rLPS and sLPS are di¡erent.
3.4. Neutrophil respiratory burst induced by LPS
In order to investigate whether sLPS and rLPS exerted
di¡erential e¡ects upon other neutrophil e¡ector functions,
we next looked at the induction of neutrophil respiratory
burst activity assessed by changes in £uorescence of
DHR123 due to oxidant generation. As shown in Fig. 5A,
in absence of fMLP stimulation, only rLPS was e¡ective in
altering intracellular oxidant species production in neutrophils
at 15 min in the presence of 1% autologous platelet-poor
plasma. It should be noted that rLPS failed to induce changes
in DHR123 £uorescence in the absence of plasma (data not
shown).
To extend these observations, fMLP-induced superoxide
anion release was measured following LPS pre-incubation
with rough and smooth LPS at 500 ng/ml in the presence of
1% autologous plasma. The release of superoxide anions was
low in unstimulated cells and addition of fMLP (1037 M)
alone caused a small increase in superoxide release (Fig.
5B,C), con¢rming that these neutrophils were not ‘primed’.
Neither rough or smooth LPS chemotypes analysed here in-
duced superoxide anion release when plasma was omitted
from the assay (data not shown). However, in the presence
of 1% plasma, both rough and smooth LPS chemotypes at
500 ng/ml caused a marked increase in superoxide anion re-
lease at both 15 and 30 min, possibly re£ecting the relatively
high concentrations used. It is interesting to note that follow-
ing 15 min pre-incubation with sLPS superoxide release was
not further augmented by fMLP, whereas a small but signi¢-
cant increase in fMLP-induced superoxide release was ob-
served for neutrophils treated with rLPS for 15 min (Fig.
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Fig. 4. Smooth LPS does not block rough LPS-induced ACLB
binding. Neutrophils were incubated in the presence of ACLB for
10 or 30 min at 37‡C with 100 or 500 ng/ml rLPS (E. coli R3) in
the presence of di¡erent concentrations of sLPS (E. coli O111) as
indicated. Data shown are from one representative experiment of
two that were performed.
Fig. 5. Neutrophil respiratory burst induced by LPS. A: Oxidant
production of neutrophils incubated with rough (E. coli R1) or
smooth LPS (E. coli O18) in the absence of fMLP for 15 min at
37‡C was determined by measurement of changes in £uorescence of
DHR123. B and C: Superoxide anion release was determined by
measuring the superoxide dismutase inhibitable reduction of cyto-
chrome c from neutrophils pre-incubated with rough LPS (E. coli
R1) or smooth LPS (E. coli O18) at 500 ng/ml for 15 min (B) or 30
min (C) followed by addition of HBSS or fMLP (1037 M). Data
presented here are mean þ S.D. of three experiments.
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5B). In contrast, at 30 min fMLP-induced release was further
augmented following pre-incubation with both LPS chemo-
types (Fig. 5C). Considering all the e¡ects of sLPS upon neu-
trophil function at 15 min, although polarisation, L2 integrin-
mediated adhesion and intracellular production of oxidant
species were not a¡ected by sLPS treatment, superoxide anion
release was augmented. One interpretation of these data might
be that sLPS might initiate two signals, a rapid direct aug-
mentation of superoxide release and a slower ‘priming’ e¡ect
associated with polarisation and increased L2 integrin activity
and augmentation of fMLP-induced superoxide release.
Whilst these data clearly show both rough and smooth LPS
chemotypes induce functional changes in neutrophils, our in-
terpretation of these ¢ndings is that rLPS acts more rapidly to
induce ‘priming’ e¡ects.
4. Discussion
Regulation of neutrophil adhesiveness is generally consid-
ered to be a key element in the development of in£ammatory
reactions. The presence of LPS in in£ammatory responses has
been linked to the pathogenesis of diseases in which neutro-
phil-mediated tissue damage occurs [2]. In this study we have
examined the e¡ect of di¡erent types of LPS upon neutrophil
L2 integrin activity and production of potentially injurious
reactive oxygen species. Rough LPS types were found to in-
duce alterations in L2 integrin activation, CD62L shedding
and intracellular production of oxidant species more rapidly
than smooth LPS types, suggesting a possible role for carbo-
hydrate modi¢cation of LPS in regulation of neutrophil acti-
vation.
L2 integrin function of neutrophils treated with the di¡erent
types of LPS was examined using a £ow cytometric assay that
measures neutrophil binding to ACLB [6,19]. Although LPS
has been suggested to bind to a number of serum proteins
including albumin, it is unlikely that LPS bind directly to
ACLB ‘opsonising’ them for binding through ‘LPS receptors’
since no ACLB were bound to neutrophils in absence of plas-
ma or serum, even at high concentration of LPS (data not
shown). Furthermore, few ACLB were bound by unstimu-
lated neutrophils and CD18 mAb e¡ectively blocked LPS-in-
duced ACLB binding (Fig. 1 and data not shown). In the
presence of low concentrations of plasma, maximum binding
was induced by all types of LPS examined here within 30 min,
but a di¡erential e¡ect of smooth and rough LPS was ob-
served at earlier time points. Dose responses of LPS clearly
indicated that observed di¡erential e¡ects were not due to
di¡erences in molecular weight of LPS chemotypes and there-
fore may re£ect altered responses of neutrophils to carbohy-
drate modi¢cation of LPS.
The key role of CD14 in responses to LPS stimulation has
been extensively demonstrated [21]. LBP/soluble CD14 com-
plexes present in serum may facilitate response to LPS by
accelerating LPS binding to CD14. A site-speci¢c mutation
in CD14 showed selective binding and transfer of E. coli
LPS but not Porphyromonas gingivalis LPS suggesting specif-
icity of binding and transfer of di¡erent LPS molecules via the
CD14 pathway [22]. Although neutrophil responses to LPS/
sCD14 and LPS/LBP complexes are thought to be similar,
rough LPS e¡ects have been suggested to be largely independ-
ent of formation of complexes with sCD14 [9]. We found a
requirement for the presence of serum components for LPS-
induced functional alterations, consistent with a role for LBP
or sCD14. Interestingly, although both rough and smooth
LPS chemotypes induced release of superoxide from neutro-
phils after 15 min, a clear di¡erential e¡ect was seen upon
polarisation, adhesion, intracellular production of oxidant
species and augmentation of fMLP-induced superoxide re-
lease, with sLPS being relatively ine¡ective at 15 min. Both
LPS chemotypes caused a similar degree of functional activa-
tion at 30 min, implying that both sLPS and rLPS can bind
neutrophils and induce intracellular signals. Our data relating
to LPS-induced changes in L2 integrin-mediated ACLB bind-
ing, DHR123 £uorescence, and fMLP-induced superoxide re-
lease would be consistent with a model in which carbohydrate
modi¢cation of LPS may attenuate transfer of LPS from LBP
to LPS receptors on the neutrophil surface. The lack of di¡er-
ential e¡ect of LPS chemotypes upon unstimulated superoxide
release at 15 min is interesting in that it raises the possibility
that glycosylation of LPS may in£uence events which may be
associated with ‘priming’.
Recent data indicate that cellular recognition and subse-
quent responses to LPS may be more complex than previously
thought. Although CD14 was shown to play an important
part in LPS responses in presence of LBP [23], a CD14-inde-
pendent LPS signalling pathway is now accepted [24,25]. It
has been recently proposed that other neutrophil receptors
may bind LPS and initiate intracellular signalling cascades.
L-selectin has been shown to bind to LPS and activate neu-
trophil e¡ector function [26], which may explain why L-selec-
tin-de¢cient mice are resistant to high doses of LPS. Further-
more, di¡erential binding of LPS from various strains of
bacteria to L-selectin was observed. Although solubility di¡er-
ences may account in part for the di¡erences in neutrophil
responsiveness to LPS from various bacteria species, L-selec-
tin has been demonstrated to bind speci¢cally to O-linked
carbohydrates [26] and alterations in the polysaccharide moi-
ety of LPS may have additional e¡ects on the activity of L-
selectin as a receptor for LPS. We are currently examining the
involvement of neutrophil receptors in mediating LPS e¡ects
reported here.
Like steroid hormones, LPS has the ability to induce syn-
thesis of new mRNA for proteins. In addition, the partial
solubility of LPS in lipid may confer the ability to penetrate
the plasma membrane and bind to the mitogen-activated pro-
tein kinase family [27]. Interestingly, our respiratory burst
data show that smooth LPS could initiate intracellular signals,
but more slowly than rough LPS. Since movement of proteins
(like G proteins) to the cell membrane is an important feature
of priming of neutrophil function by LPS, an alteration in
LPS structure may a¡ect lipid permeability and thus the ca-
pacity for binding intracellular compartments to modify pro-
tein translocation within the cell. The extent of glycosylation
of LPS may, like dephosphorylation or deacylation, a¡ect the
ability of the lipid A moiety of LPS to be e¡ective as an
in£ammatory mediator.
Conditions associated with septic shock or acute respiratory
distress syndrome are characterised by activation and accu-
mulation of leukocytes in tissues. The observation that neu-
trophil responsiveness to various LPS species can be in£u-
enced by the polysaccharide moiety of LPS point to new
features in the mechanism of action of LPS. Carbohydrate
modi¢cation of LPS by bacteria may confer some degree of
protection against induction of host responses which have
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important implications for the regulation of neutrophil e¡ec-
tor function during the in£ammatory response.
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